Dana Farber Cancer Institute SC (1)

Boston, Massachusetts 02215

0 studies enrolling now · 2 studies all time

What they study most

Advanced Malignancies That Harbor IDHR132 Mutations, Glioblastoma

Studies at this site

• A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations — Running, not enrolling
• A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma — Completed